Previous Article | Next Article 
Journal of Clinical Microbiology, July 2003, p. 3336-3338, Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3336-3338.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Comparison of Genotyping Helicobacter pylori Directly from Biopsy Specimens and Genotyping from Bacterial Cultures
Chang-Young Park,1,2 Minjung Kwak,3 Oscar Gutierrez,4 David Y. Graham,1 and Yoshio Yamaoka1*
Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas,1
Department of Internal Medicine, Kangbuk Samsung Hospital, Sunkyunkwan University School of Medicine, Seoul,2
Department of Information of Statistics, Pyongtaek University, Pyongtaek, Korea,3
Department of Medicine, Universidad Nacional de Colombia, Bogota, Colombia4
Received 10 December 2002/
Returned for modification 18 January 2003/
Accepted 21 April 2003

ABSTRACT
PCR for
vacA and
cagA genotypes of
Helicobacter pylori using
DNA isolated from infected gastric biopsy specimens was approximately
equal to genotyping using bacterial DNA from cultures. Inconsistent
results were associated with low
H. pylori density in biopsies.
A higher proportion of mixed infection was found when biopsies
were used.

TEXT
Peptic ulcer or gastric cancer is most likely associated with
cag pathogenicity island (PAI)-positive
Helicobacter pylori strains (
3,
4). Although attempts to associate specific mosaic
combinations of signal sequences (s1a, s1b, s1c, and s2) and
middle region allelic types (m1 and m2) of the
vacA gene have
met with little success, there is interest in genotyping
H. pylori in relation to this factor (
1,
8,
11). This study was
undertaken to determine whether genotyping with DNA extracted
from gastric biopsy specimens provided results similar to those
with bacterial DNA isolated from
H. pylori cultured from gastric
biopsies.
DNA from serial dilutions of H. pylori cells (0 to 106 bacteria per PCR) from strains ATCC 43504 (vacA s1a-m1, cagA positive), ATCC 51932 (vacA s2-m2, cagA negative) and C90 (vacA s1b-m1, cagA positive) was used to define the accuracy of the cagA and vacA PCR assays (Table 1). PCR amplification was performed as previously described (11). PCR products with the expected band size were regarded as positive for the target genes. PCR for the cag empty site was used to confirm the absence of the entire cag PAI (6). If both cagA and empty site PCRs were positive, the sample was scored as a mixed cagA-positive and cagA (or cag PAI)-negative infection. If both cagA and empty site PCRs were negative, the samples were recorded as having no band (NB). Genotyping with bacterial DNA was possible with as few as 10 bacteria per PCR, although the cag empty site required 100 bacteria per PCR (Table 2). The specificity of the PCR assay was confirmed with 37 related and unrelated bacteria, including 3 Helicobacter species and 4 Campylobacter species (5). All primers proved specific for H. pylori.
We simulated mucosal biopsies by adding approximately 50 mg
of noninfected gastric mucosal tissues to each of 96 wells of
a microtiter plate along with serial dilutions of
H. pylori suspended in RPMI 1640 medium (Invitrogen Corp., Carlsbad, Calif.).
After 2 h of incubation at 37°C with 5% CO
2 to enhance attachment
and bacterial tissue interactions, samples in the plates were
centrifuged at 12,000
x g for 1 min, the supernatants were discarded,
and DNA was extracted from the pellets by using the QIAamp tissue
kit (QIAGEN, Inc.) (spiked-tissue experiment). Tissue DNA without
added
H. pylori served as negative controls, and no PCR bands
were detected, again confirming specificity for
H. pylori. With
the exception for genotypes of
vacA s,
vacA s1a, and the
cag empty site, PCR using simulated biopsy tissue required a minimum
of 10 times more DNA than genotyping using bacterial DNA (Table
2).
We simulated mixed infection by adding approximately 50 mg of noninfected gastric mucosal tissues to each of 96 wells along with two different genotypes of H. pylori (103 to 105 CFU of each strain) suspended in RPMI 1640 medium (Invitrogen). This number of bacteria was based on our prior experience and published data showing that the concentration of H. pylori in gastric mucosal biopsies was typically in the range of 5 x 103 to 5 x 105 bacteria per biopsy sample (2, 10). We used two vacA s1a-m1, cagA-positive strains (ATCC 43504 and JK31), two vacA s1b-m1, cagA-positive strains (C90 and C91), and two vacA s2-m2, cagA-negative strains (ATCC 51932 and C94) for the mixed spiked-tissue experiments. For each genotype, we tested one fast-growing strain and one slow-growing strain based on the time required to reach a plateau in liquid culture.
Using a starting bacterial dose of approximately 106 bacteria, fast growers required approximately 10 h, and slow growers required approximately 30 h to reach the same cell density. Samples were handled as described above (in vitro spiked-tissue experiment). Homogenized tissues were cultured before DNA extraction, and DNA corresponding to 106 bacteria from multiple colonies was used for each PCR. In the mixed spiked-tissue experiment, we could detect both genotypes irrespective of the rate of growth and the starting dilution (103 and 105 [1:100] to 105 and 103 [100:1]). However, genotyping results following coculture of fast- and slow-growing strains was observed to be dependent on both the rate of growth and the starting dilution (Table 3). Only when the before-culture growth ratio (slow/fast) of the two strains was 1% or less were the results other than "mixed culture." When we used two strains with the same growth speed (fast or slow), we could correctly genotype the strains irrespective of the starting ratios, which varied between 1:100 and 100:1.
We finally examined the gastric mucosal biopsy specimens from
166
H. pylori culture-positive Colombian patients in which mixed
infection is common (
9,
12). Informed consent was obtained from
all patients, and the ethics committee of Universidad Nacional
de Colombia approved the protocol. Antral biopsy specimens were
sent frozen on dry ice to Houston, where they were defrosted
and homogenized by grinding. The wet weights were approximately
50 mg in each sample. Genomic DNA was directly extracted from
biopsy specimens as described for the spiked-tissue experiments.
The homogenized material was also cultured, and DNA from multiple
colonies was extracted as described above. Again, DNA corresponding
to 10
6 bacteria per PCR was used. There was good agreement between
PCR-based genotyping results with tissue DNA and those with
bacterial DNA, especially for
vacA m1 versus m2 and
vacA s1
versus s2 (Table
4). Inconsistencies between results from PCR
from the biopsy samples and culture of the sample were possibly
due to differences in growth rate among the strains present
in the stomach or the numbers of organisms per strain. The interpretation
of the results to determine which approach was superior depended
on how one handled the data regarding mixed infections. Use
of PCR from the biopsy specimen showed 32 cases with mixed
vacA s1a and s1b strain, whereas PCR from bacteria recovered by culture
revealed only 10 cases. Overall, we detected mixed infection
(defined as evidence of two strains with any of the genes examined)
in 27% of cases when we used tissue DNA compared to only 9%
when we used bacterial DNA. In gastric cancer specimens, there
was only fair-to-moderate agreement in genotyping between tissue
DNA and bacterial DNA for the
vacA s1 subtype, because there
were many cases with mixed infection of s1a and s1b genotypes
in tissue DNA (19 of 51 [37%] versus 3 of 51 [6%], respectively).
Thus, studies to identify relationships between virulence factors
and disease presentation (e.g., gastric cancer) should be restricted
to sites where mixed infection is uncommon. However, excluding
mixed infections when they are common might produce a misleading
perception of the actual relationships of bacterial strains
to pathology of the diseases (
8).
Direct PCR from biopsy specimens tended to underestimate the
prevalence of a specific virulence factor such as
cagA (e.g.,
in 14 cases, or 8.4%, NB was detected with
cagA, although the
culture showed infection with a
cagA-positive strain) (Table
4). All of these cases had low
H. pylori density by histology
(data not shown), suggesting that low
H. pylori density in biopsy
specimens may result in misleading results with direct PCR.
Partial deletion of the
cag PAI could also yield
cagA-negative
and
cag empty-site-negative results (i.e., NB). However, because
bacterial DNA yielded positive
cagA results for the same cases,
the possibility of a partially deleted
cag PAI is thought to
be rare.
Cases with inconsistent genotypes were fortunately rare (Table 4): all such cases had very low H. pylori density by histology, and the positive bands were faint (data not shown), suggesting that there was insufficient DNA from the biopsy samples to correctly genotype these cases. Direct PCR analysis of gastric biopsy specimens is less tedious and time-consuming than culturing of the strains, and it is theoretically possible to perform genotyping from formalin-fixed paraffin-embedded gastric biopsy specimens (7). Clinically, it would be important to include positive and negative controls to exclude the possibility of inhibitors of the PCR in the tissue sample. The use of real-time PCR or Southern hybridization might also provide improved results.

FOOTNOTES
* Corresponding author. Mailing address: Veterans Affairs Medical Center (111D), 2002 Holcombe Blvd., Houston, TX 77030. Phone: (713) 794-7597. Fax: (713) 790-1040. E-mail:
yyamaoka{at}bcm.tmc.edu.


REFERENCES
1 - Atherton, J. C., P. Cao, R. M. Peek, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J. Biol. Chem. 270:17771-17777.[Abstract/Free Full Text]
2 - Atherton, J. C., K. T. Tham, R. M. Peek, T. L. Cover, and M. J. Blaser. 1996. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 174:552-556.[Medline]
3 - Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. I. Cover, R. M. Peek, and P. H. Chyou. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.[Abstract/Free Full Text]
4 - Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.[Abstract/Free Full Text]
5 - Hulten, K., S. W. Han, H. Enroth, P. D. Klein, A. R. Opekun, R. H. Gilman, D. G. Evans, L. Engstrand, D. Y. Graham, and F. A. El-Zaatari. 1996. Helicobacter pylori in the drinking water in Peru. Gastroenterology 110:1031-1035.[CrossRef][Medline]
6 - Mukhopadhyay, A. K., D. Kersulyte, J.-Y. Jeong, S. Datta, Y. Ito, A. Chowdhury, S. Chowdhury, A. Sandra, S. K. Bhattacharya, T. Azuma, B. Nair, and D. E. Berg. 2000. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J. Bacteriol. 182:3219-3227.[Abstract/Free Full Text]
7 - Scholte, G. H. A., L. J. van Doorn, W. G. V. Quint, and J. Lindeman. 2001. Genotyping of Helicobacter pylori strains in formalin-fixed or formaledhyde-sublimate-fixed paraffin-embedded gastric biopsy specimens. Diagn. Mol. Pathol. 10:166-170.[CrossRef][Medline]
8 - van Doorn, L. J., C. Figueriedo, R. Sanna, A. Plaisier, P. Schneeberger, W. D. Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115:58-66.[CrossRef][Medline]
9 - Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37:2274-2279.[Abstract/Free Full Text]
10 - Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1999. Relation between clinical presentation, Helicobacter pylori density, interleukin-1ß and -8 production, and cagA status. Gut 45:804-811.[Abstract/Free Full Text]
11 - Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1998. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 4:241-253.
12 - Yamaoka, Y., H. M. T. El-Zimaity, O. Gutierrez, N. Figura, J. G. Kim, T. Kodama, K. Kashima, and D. Y. Graham. 1999. Relationship between subtypes of the cagA 3' repeat region, gastric histology, and susceptibility to low pH. Gastroenterology 117:342-349.[CrossRef][Medline]
Journal of Clinical Microbiology, July 2003, p. 3336-3338, Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3336-3338.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sugimoto, M., Wu, J.-Y., Abudayyeh, S., Hoffman, J., Brahem, H., Al-Khatib, K., Yamaoka, Y., Graham, D. Y.
(2009). Unreliability of Results of PCR Detection of Helicobacter pylori in Clinical or Environmental Samples. J. Clin. Microbiol.
47: 738-742
[Abstract]
[Full Text]
-
Megraud, F., Lehours, P.
(2007). Helicobacter pylori Detection and Antimicrobial Susceptibility Testing. Clin. Microbiol. Rev.
20: 280-322
[Abstract]
[Full Text]
-
Kudo, M, Gutierrez, O, El-Zimaity, H M T, Cardona, H, Nurgalieva, Z Z, Wu, J, Graham, D Y
(2005). CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J. Clin. Pathol.
58: 259-262
[Abstract]
[Full Text]
-
Chattopadhyay, S., Patra, R., Ramamurthy, T., Chowdhury, A., Santra, A., Dhali, G. K., Bhattacharya, S. K., Berg, D. E., Nair, G. B., Mukhopadhyay, A. K.
(2004). Multiplex PCR Assay for Rapid Detection and Genotyping of Helicobacter pylori Directly from Biopsy Specimens. J. Clin. Microbiol.
42: 2821-2824
[Abstract]
[Full Text]